We are live on ! Find out more
Viking Global Investors

Viking Global Investors Portfolio holdings

AUM $35.7B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
-0.25%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$26B
AUM Growth
-$840M
Cap. Flow
-$234M
Cap. Flow %
-0.9%
Top 10 Hldgs %
41.42%
Holding
108
New
25
Increased
27
Reduced
18
Closed
26

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$830M
2
DASH icon
DoorDash
DASH
+$667M
3
JPM icon
JPMorgan Chase
JPM
+$588M
4
NFLX icon
Netflix
NFLX
+$583M
5
DLTR icon
Dollar Tree
DLTR
+$500M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$1.77B
2
AMD icon
Advanced Micro Devices
AMD
+$713M
3
DHR icon
Danaher
DHR
+$709M
4
GE icon
GE Aerospace
GE
+$480M
5
UNH icon
UnitedHealth
UNH
+$451M

Sector Composition

Rank Sector Weight
1 Technology 25.47%
2 Healthcare 17.32%
3 Financials 15.71%
4 Consumer Discretionary 15.6%
5 Industrials 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
51
Sherwin-Williams
SHW
$88.5B
$122M 0.47%
+407,786
New +$126M
APO icon
52
Apollo Global Management
APO
$80.8B
$115M 0.44%
+971,224
New +$110M
ADPT icon
53
Adaptive Biotechnologies
ADPT
$4.04B
$109M 0.42%
29,993,708
CRM icon
54
Salesforce
CRM
$162B
$104M 0.4%
+405,135
New +$108M
LAB icon
55
Standard BioTools
LAB
$309M
$104M 0.4%
58,651,170
OSCR icon
56
Oscar Health
OSCR
$8.63B
$93.8M 0.36%
5,928,038
+1,196,036
+25% +$22M
PCOR icon
57
Procore
PCOR
$8.93B
$91.1M 0.35%
1,374,580
+383,351
+39% +$26.6M
ALL icon
58
Allstate
ALL
$66.3B
$87M 0.33%
+545,182
New +$90.9M
MCK icon
59
McKesson
MCK
$105B
$83M 0.32%
142,169
-448,411
-76% -$250M
FIVN icon
60
FIVE9
FIVN
$2.44B
$76.5M 0.29%
1,734,414
-1,717,724
-50% -$89.3M
NRG icon
61
NRG Energy
NRG
$25.2B
$73.5M 0.28%
+943,457
New +$73.1M
VKTX icon
62
Viking Therapeutics
VKTX
$3.94B
$71.8M 0.28%
1,354,450
+259,510
+24% +$17M
CVNA icon
63
Carvana
CVNA
$79.2B
$71.3M 0.27%
+2,768,105
New +$55.7M
INSM icon
64
Insmed
INSM
$29B
$69.4M 0.27%
+1,035,970
New +$40.2M
PHVS icon
65
Pharvaris
PHVS
$2.41B
$68.7M 0.26%
3,653,310
FDMT icon
66
4D Molecular Therapeutics
FDMT
$600M
$61.6M 0.24%
2,934,914
IMVT icon
67
Immunovant
IMVT
$8.45B
$61.3M 0.24%
2,320,902
+511,730
+28% +$14.6M
VRT icon
68
Vertiv
VRT
$108B
$59.7M 0.23%
689,687
-328,307
-32% -$29.9M
KKR icon
69
KKR & Co
KKR
$99.6B
$57.4M 0.22%
545,092
-526,074
-49% -$53.6M
DNA icon
70
Ginkgo Bioworks
DNA
$506M
$47.8M 0.18%
3,577,128
LBPH
71
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$44.8M 0.17%
1,658,962
+677,634
+69% +$13.4M
LPLA icon
72
LPL Financial
LPLA
$29.2B
$36.3M 0.14%
+130,000
New +$35.3M
ZLAB icon
73
Zai Lab
ZLAB
$2.92B
$35.3M 0.14%
2,037,374
-10,755
-0.5% -$189K
DAWN
74
DELISTED
Day One Biopharmaceuticals
DAWN
$35.3M 0.14%
2,558,563
ORIC icon
75
Oric Pharmaceuticals
ORIC
$1.42B
$28.3M 0.11%
4,000,000

Similar funds

Viking Global Investors's Q2 2024 Portfolio in Review

As of Q2 2024, Viking Global Investors held 108 positions worth $26B, down 3.1% from $26.9B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Viking Global Investors's Q2 2024 filing shows 25 new, 27 increased, 18 reduced and 26 closed positions. Its largest new stake was DoorDash: 5,535,921 shares worth $602M. The largest sale was Visa, an estimated $1.77B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Viking Global Investors's largest Q2 2024 buy was DoorDash: 5,535,921 shares worth $602M.
  • Viking Global Investors added most to Adobe in Q2 2024, an estimated $830M increase.
  • Viking Global Investors's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $451M.
  • Viking Global Investors fully exited Visa in Q2 2024, selling an estimated $1.77B.
  • Viking Global Investors's ten largest holdings make up 41% of its $26B portfolio in Q2 2024.
  • Viking Global Investors opened 25 new positions and closed 26 in Q2 2024.
  • Viking Global Investors's portfolio value fell 3.1% quarter-over-quarter to $26B.

Based on Viking Global Investors's 13F filing for Q2 2024, filed 14 Aug 2024.